Average Co-Inventor Count = 8.92
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Aktiengesellschaft (18 from 12,157 patents)
2. Bayer Healthcare Aktiengesellschaft (5 from 76 patents)
3. Bayer Schering Pharma Ag (2 from 192 patents)
4. Bayer Pharmaceuticals Corporation (1 from 70 patents)
5. Bayer Aktlengesellschaft (1 from 1 patent)
27 patents:
1. 7704999 - 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
2. 7696206 - 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
3. 7314871 - 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension
4. 7276504 - Use of 2-alkoxyphenyl-substituted imidazotriazinones
5. 7122540 - 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
6. 7098207 - Imidazotriazinones and the use thereof
7. 7091203 - Imidazo[1,3,5]triazinones and their use
8. 7015246 - Benzofuran derivatives
9. 6943163 - 7-Alkyl and cycloalkyl-substituted imidazotriazinones
10. 6930108 - Use of 2-alkoxyphenol-substituted imidazotriazinones
11. 6900194 - Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
12. 6890922 - 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
13. 6878708 - Imidazotriazinones and the use thereof
14. 6838459 - 7-alkyl-and cycloalkyl-substituted imidazotriazinones
15. 6803480 - Diphenylmethane derivatives